Renewing the National Commitment to Fight Alzheimer’s

Our advocates have pushed Congress to make great progress in the fight against Alzheimer’s and all other dementia. Thanks to our bipartisan congressional champions and dedicated advocates, federal research funding has grown and individuals living with Alzheimer’s and their caregivers have access to better quality care and support services. But much more work remains.

NAPA Reauthorization Act

Wysiwyg

The bipartisan NAPA Reauthorization Act (S. 4203 / H.R. 7775) would build on the progress made in the fight against Alzheimer’s and other dementia over the last decade by reauthorizing the National Alzheimer’s Project Act (NAPA) (P.L. 111-375), landmark legislation signed into law in 2011. 

The NAPA Reauthorization Act emphasizes the importance of healthy aging and risk reduction for Alzheimer’s disease to reflect the new sixth goal of the National Plan. The legislation also adds new federal representatives to the NAPA Advisory Council from the Department of Justice (DoJ), the Federal Emergency Management Agency (FEMA), and the Social Security Administration (SSA). Additionally, the NAPA Reauthorization Act underscores and addresses health disparities among underrepresented populations.

Alzheimer’s Accountability and Investment Act

Wysiwyg

With the original provisions of the Alzheimer’s Accountability Act, which was enacted in 2014, set to expire in 2025, Congress must renew its commitment to ensure that progress continues to be made in Alzheimer’s and dementia research. The bipartisan Alzheimer’s Accountability and Investment Act (S. 4202 / H.R. 7773) would continue to prioritize Alzheimer’s and dementia research funding at the NIH.

NAPA Chart

The bipartisan Alzheimer’s Accountability and Investment Act would require the National Institutes of Health (NIH) to continue to submit an annual Professional Judgment Budget to Congress to ensure Alzheimer’s and dementia research is funded at the levels needed to achieve the goals in the National Plan to Address Alzheimer’s Disease. With robust and steady investment, scientists will be able to work faster to advance basic disease knowledge, explore ways to reduce risk, uncover new biomarkers for early diagnosis and drug targeting, and develop potential treatments.

AIM is proud to support these important bipartisan bills. Join us to build momentum for the NAPA Reauthorization Act and the Alzheimer’s Accountability and Investment Act in Congress.

Zach Rosenfeld and mother

I advocate...because this problem impacts me personally. My grandmother has Alzheimer’s. My grandfather had Alzheimer’s. This is a personal issue for me, but more than that, it’s an issue that’s personal for so many others."

—Zach R., New York
Two Advocates Outside

Be a Champion in the Fight to End Alzheimer’s

Our voices are stronger together. Help AIM advance legislation to improve the lives of people impacted by Alzheimer’s and all other dementia.

  • Share your story with elected officials
  • Engage on social media
  • Write a letter to the editor

NAPA Reauthorization Act and Alzheimer’s Accountability and Investment Act Resources

The following resources will help you learn more about the NAPA Reauthorization Act and the Alzheimer’s Accountability and Investment Act and how AIM is working to build on the progress made in the fight against Alzheimer’s and other dementia.

Congress building

Find a Member of Congress

Learn where your member of Congress stands on AIM’s policy priorities and how you can help gain their support in the fight to end Alzheimer’s and all other dementia.